Home Tags 21st Congress of the European Hematology Association (EHA)

Tag: 21st Congress of the European Hematology Association (EHA)

Study Shows High Remission Rate in Leukemia Patients Treated with Inotuzumab...

In an open-label, randomized Phase III INO-VATE ALL study, also known as study 1022, of the investigational drug inotuzumab ozogamicin, also known as CMC-544 (Pfizer), a...

Amgen Presents TOWER Study During 21st Congress of the European Hematology...

During the upcoming 21st Congress of the European Hematology Association (EHA), the premier hematology congress in Europe being held June 9-12, 2016, in Copenhagen, Denmark, Amgen...

FEATURED RESOURCES